Catherine A. Abbott
Impact in
- Oncology top 2%
- Peptidase Inhibition and Analysis
-
- Neuropeptides and Animal Physiology
Papers in
- Oncology 43
- Peptidase Inhibition and Analysis 39
-
- Neuropeptides and Animal Physiology 27
- Co-authors
- Geoffrey W. McCaughanMark D. GorrellRoger YazbeckGordon S. HowarthKirsten BenkendorffKaterina AjamiMiriam LevyDenise Yu
- Journals
- Advances in experimental medicine and biology (4 papers)Scientific Reports (3 papers)Marine Drugs (3 papers)Ecology and Evolution (3 papers)Evidence-based Complementary and Alternative Medicine (3 papers)
- Partner nations
- AustraliaGermanyUnited States
In The Last Decade
Catherine A. Abbott
72 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 129
- Oncology 1.6k
- Cellular and Molecular Neuroscience 890
- Endocrinology, Diabetes and Metabolism 666
- Cancer Research 410
- Hepatology 189
Countries citing papers authored by Catherine A. Abbott
This map shows the geographic impact of Catherine A. Abbott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine A. Abbott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine A. Abbott more than expected).
Fields of papers citing papers by Catherine A. Abbott
This network shows the impact of papers produced by Catherine A. Abbott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine A. Abbott. The network helps show where Catherine A. Abbott may publish in the future.
Co-authors
The 25 scholars most cited alongside Catherine A. Abbott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2021 | 37 | |
| 4 | 2019 | 14 | |
| 5 | 2014 | 9 | |
| 6 | 2013 | 56 | |
| 7 | 2013 | 11 | |
| 8 | 2010 | 11 | |
| 9 | 2010 | 39 | |
| 10 | 2010 | 52 | |
| 11 | 2009 | 33 | |
| 12 | 2006 | 3 | |
| 13 | 2006 | 10 | |
| 14 | 2006 | 4 | |
| 15 | 2006 | 8 | |
| 16 | 2006 | 12 | |
| 17 | 2003 | 0 | |
| 18 | 2003 | 43 | |
| 19 | 1997 | 10 | |
| 20 | 1993 | 13 |
About Catherine A. Abbott
Catherine A. Abbott is a scholar working on Oncology, Cellular and Molecular Neuroscience, Endocrinology, Diabetes and Metabolism, Biotechnology and Cancer Research, having authored 74 papers that have together received 2.8k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (39 papers), Neuropeptides and Animal Physiology (27 papers), Diabetes Treatment and Management (14 papers), Protease and Inhibitor Mechanisms (7 papers), Signaling Pathways in Disease (7 papers), Gut microbiota and health (6 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and Marine Sponges and Natural Products (4 papers). The work is most often cited by research in Oncology (1.6k citations), Cellular and Molecular Neuroscience (890 citations), Endocrinology, Diabetes and Metabolism (666 citations), Cancer Research (410 citations) and Hepatology (189 citations). Catherine A. Abbott has collaborated with scholars based in Australia, Germany and United States. Frequent co-authors include Geoffrey W. McCaughan, Mark D. Gorrell, Roger Yazbeck, Gordon S. Howarth, Kirsten Benkendorff, Katerina Ajami, Miriam Levy, Denise Yu, Nicholas Shackel and Peter H. McGuinness. Their work appears in journals such as Advances in experimental medicine and biology, Scientific Reports, Marine Drugs, Ecology and Evolution and Evidence-based Complementary and Alternative Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.